EARLY INFECTIOUS COMPLICATIONS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR HIGH-RISK NEUROBLASTOMA: HIGH IMPACT ON MORTALITY AND MORBIDITY

被引：0
|
作者：
Noun, Dolly [1 ]
Ghanem, Khaled [1 ]
Dhayni, Raghida [1 ]
Hariss, Nariman [1 ]
Muakkit, Samar [1 ]
Saab, Raya [1 ]
Hamideh, Dima [1 ]
El-Solh, Hassan [1 ]
Abboud, Miguel [1 ]
Tarek, Nidale [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
919
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FACTORS IMPACTING TIME TO ENGRAFTMENT IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT
    Hillier, Kirsty
    Foster, Jennifer
    Cheng, W.
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [2] Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant
    Hillier, Kirsty
    Cheng, W. Susan
    Whittle, Sarah B.
    Krance, Robert
    Foster, Jennifer H.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (07) : E569 - E574
  • [3] Factors impacting time to engraftment in patients with high-risk neuroblastoma following autologous stem cell transplant
    Hillier, Kirsty
    Krance, Robert
    Foster, Jennifer Haunani
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] ACQUIRED HEMOPHILIA A FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK NEUROBLASTOMA
    Mitani, Yuichi
    Arakawa, Yuki
    Mori, Makiko
    Fukuoka, Kohei
    Oshima, Koichi
    Niitsu, Takehiro
    Kawashima, Hiroshi
    Fujinaga, Shuichiro
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [5] Autologous stem cell transplantation for high-risk neuroblastoma: the Iranian experience
    Hamidieh, A. A.
    Alimoghaddam, K.
    Huoseini, A.
    Jorjani, H.
    Jalali, A.
    Derakhshandeh, R.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S384 - S385
  • [6] Immune System Profiling Following Autologous Stem Cell Transplant for High-Risk Neuroblastoma Predicts Disease-Free Survival
    Nassin, Michele L.
    Nicolaou, Elitsa V.
    Hecktman, Hillary M.
    Cohen, Caitlin W.
    Cohn, Susan L.
    Cunningham, John M.
    LaBelle, James L.
    BLOOD, 2016, 128 (22)
  • [7] Clinical Prognostic Factors in Patients with High-risk Neuroblastoma Undergoing A Single Autologous Stem Cell Transplant
    Saito, Yuya
    Kiyotani, Chikako
    Inoue, Masami
    Takahashi, Yoshiyuki
    Ogawa, Atsushi
    Chin, Motoaki
    Koga, Yuuki
    Kato, Koji
    Koh, Katsuyoshi
    Watanabe, Kenichiro
    Hashii, Yoshiko
    Sato, Atsushi
    Atsuta, Yuko
    Matsumoto, Kimikazu
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S42 - S42
  • [8] Autologous stem cell transplant for high-risk neuroblastoma: Achieving cure with low-cost adaptations
    Jain, Richa
    Hans, Rekha
    Totadri, Sidharth
    Trehan, Amita
    Sharma, Ratti Ram
    Menon, Prema
    Kapoor, Rakesh
    Saxena, Akshay Kumar
    Mittal, Bhagwant Rai
    Bhatia, Prateek
    Kakkar, Nandita
    Srinivasan, Radhika
    Rajwanshi, Arvind
    Varma, Neelam
    Samujh, Ram
    Marwaha, Neelam
    Bansal, Deepak
    PEDIATRIC BLOOD & CANCER, 2020, 67 (06)
  • [9] Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta
    Jain, Richa
    Trehan, Amita
    Menon, Prema
    Kapoor, Rakesh
    Kakkar, Nandita
    Radhika, Srinivasan
    Saxena, Akshay Kumar
    Mittal, Bhagwant Rai
    Varma, Neelam
    Samujh, Ram
    Bansal, Deepak
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (04) : 291 - 304
  • [10] Impact of CD34+Cell Dose on Outcome in Children Undergoing Autologous Hematopoietic Stem Cell Transplant for High-Risk Neuroblastoma
    Knight, Tristan E.
    Ahn, Kwang Woo
    Hebert, Kyle
    Wall, Donna A.
    Atshan, Rasha
    Broglie, Larisa
    Schultz, Kirk R.
    Qayed, Muna
    Eapen, Mary
    Yanik, Gregory A.
    PEDIATRIC BLOOD & CANCER, 2022, 69
12345